Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Clicks: 474
ID: 116728
2004
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The majority of successfully treated EBV-HLH patients have a good outcome and remain disease-free.
Reference Key
s2004haematologicalongitudinal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Imashuku S;Teramura T;Tauchi H;Ishida Y;Otoh Y;Sawada M;Tanaka H;Watanabe A;Tabata Y;Morimoto A;Hibi S;Henter JI;;
Journal Haematologica
Year 2004
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/15003893
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine prognosis treatment outcome research support non-u.s. gov't female male adolescent Child Infant Remission Induction Prospective Studies preschool Multicenter Study herpesvirus 4 follow-up studies immunoglobulins immunotherapy Cohort Studies Survival Analysis drug therapy combination cause of death histiocytosis combined modality therapy dexamethasone / administration & dosage etoposide / administration & dosage etoposide / therapeutic use virus activation dexamethasone / therapeutic use non-langerhans-cell / therapy* japan / epidemiology intravenous / therapeutic use human / growth & development pmid:15003893 shinsaku imashuku tomoko teramura jan-inge henter cord blood stem cell transplantation epstein-barr virus infections / mortality epstein-barr virus infections / therapy* non-langerhans-cell / mortality non-langerhans-cell / virology peripheral blood stem cell transplantation

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.